We expect that chromatid paints will fulfill multiple needs in several fields related to human health. A major market for inversion detection is the screening of cancer cells for previously undetected inversions that are causal. New cancer specific inversions may lead to diagnostic and prognostic tests and may even lead to eventual drug targeting. Other markets include, but are not limited to: clinical cytogenetics (cancer diagnosis and prognosis, detection and diagnosis of certain neurological disorders associated with inverted copy number variants, infertility diagnosis and genetic counseling); biomedical research (mechanistic studies of cancer induction, radiation effects, and chemical toxicology); and governmental agencies (retrospective biodosimetry-evaluation of radiation exposure as might occur accidentally or from a terrorist attack). Ultimately, multi-color chromatid paints will provide genome-wide translocation identification, just as mFISH and SKY currently do, and in addition will allow simultaneous and sensitive detection of inversions, making it possible, even probable, that chromatid paints may eventually capture much of the market currently held by chromosome paints. Three applications of interest to NASA are: 1) Retrospective biodosimetry, the estimation of radiation dose based on observed biological damage at a time point considerably after the exposure; 2) Ongoing chromosomal analysis of astronaut lymphocytes provides a measure of accumulated genetic damage caused by space radiation exposure. Chromatid paints will increase sensitivity of this analysis by adding a new class of observable aberrations; and 3) Biology-based space radiation risk analysis efforts. Chromosome aberrations play a causative role in carcinogenesis, as does gene copy number imbalance and cytogenetically invisible point mutations. One way to bring knowledge of cancer genetics into risk analysis is to estimate dose- and LET-dependent probabilities for specific cancer-related genetic alterations. Although some large inversions that can be detected are known to be associated with certain cancers, adequate investigation of cancer-specific chromosomal inversions is currently not possible, and therefore many such inversions, especially small ones, undoubtedly remain undiscovered. This shortcoming is pertinent with regard to charged particle exposures in that small inversions are likely to be among the most common and most stable chromosome aberration created. Chromatid paints have the potential to contribute to biology-based risk analysis through their ability to reveal these previously cryptic, currently predicted small cancer-related inversions for the first time.